 |
Lucinactant |
|---|---|
| Trade Name | Surfaxin(R), Aerosurf(R) |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2010-10-21 00:00:00 |
| Sponsor | Windtree Therapeutics, Inc.;2600 Kelly Road, Suite 100;Warrington, Pennsylvania, 18976 |
Related Access Program